You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: March 13, 2025

Patent: 5,428,522


✉ Email this page to a colleague

« Back to Dashboard


Summary for Patent: 5,428,522
Title: Four quadrant unipolar pulse width modulated inverter
Abstract:A four quadrant unipolar pulse width modulated (PWM) power conversion circuit for supplying a desired current to an inductive load uses an H-bridge circuit topology with an upper and lower pair of switching elements including a diode in parallel with each of the switching elements to provide a current path from the load to the power source when its respective switching element is non-conductive. A control algorithm generates switching element control signals to cause the instantaneous voltage across the load to alternate between a single polarity voltage and zero for a portion of the output load waveform to cause the average value of the load current to correspond generally with the desired average load current.
Inventor(s): Millner; Alan (Lexington, MA), Mongeau; Peter P. (Westborough, MA), Daboussi; Zaher (Boylston, MA)
Assignee: Kaman Electromagnetics Corporation (Hudson, MA)
Application Number:07/931,196
Patent Claims:see list of patent claims
Patent landscape, scope, and claims summary:

Analyzing the Claims and Patent Landscape of United States Patent 5,428,522

Introduction

Understanding the intricacies of a patent, particularly one like United States Patent 5,428,522, involves a thorough analysis of its claims, the patent landscape, and the legal and procedural context in which it exists. This article will delve into the key aspects of patent analysis, using U.S. Patent 5,428,522 as a case study.

Patent Basics

Before diving into the specifics of U.S. Patent 5,428,522, it is essential to understand the basic criteria for patentability. A patent must meet the criteria of novelty, usefulness, and nonobviousness[2].

Novelty

The invention must be new and not previously known or used by others. This includes ensuring that the invention has not been described in writing in a patent or other printed publication before the patent application.

Usefulness

The invention must be capable of use and provide an identifiable benefit. This excludes abstract ideas and ensures the invention has practical applications.

Nonobviousness

The invention must not be obvious to a person of ordinary skill in the art. This involves determining whether the combination of existing knowledge would lead someone to the invention with a reasonable expectation of success[2].

Understanding Patent Claims

Patent claims are the heart of a patent, defining the scope of the invention and what is protected. Here are some key points to consider:

Types of Claims

  • Independent Claims: These claims stand alone and define the invention without reference to other claims.
  • Dependent Claims: These claims refer back to and further limit the scope of an independent claim[2].

Claim Construction

The interpretation of patent claims is crucial for determining their scope. This involves understanding the language used, the context within the patent specification, and any relevant prior art[3].

The Patent Landscape

The patent landscape includes all related patents and applications within a family, as well as prior art and competing patents.

Patent Families

A patent family includes all related patents and applications filed in different jurisdictions. Understanding the scope and coverage of these patents is essential for making informed decisions about licensing, challenging validity, and allocating R&D resources[3].

Prior Art and Obviousness-Type Double Patenting (ODP)

Prior art refers to existing knowledge and inventions that could affect the novelty and nonobviousness of a patent. ODP is a concept that prevents an inventor from securing a second, later-expiring patent for an invention covered by a previously granted patent, especially when the later patent has a different term due to Patent Term Adjustment (PTA)[1].

Case Study: U.S. Patent 5,428,522

Background

To analyze U.S. Patent 5,428,522, one would need to review the patent specification, claims, and any relevant prior art. Here are some steps to consider:

Reviewing the Patent Specification

  • Title and Abstract: Understand the general nature of the invention.
  • Detailed Description: Analyze the detailed description of the invention, including drawings and examples.
  • Claims: Examine the independent and dependent claims to determine the scope of protection[2].

Analyzing Claims

  • Claim Construction: Interpret the claims in light of the specification and prior art.
  • Dependent Claims: Determine how dependent claims further limit the scope of the independent claims.

Prior Art and ODP Analysis

  • Prior Art Search: Conduct a thorough search to identify any prior art that could affect the novelty and nonobviousness of the claims.
  • ODP Considerations: If the patent has been granted PTA, consider whether ODP analysis should be based on the adjusted expiration date of the patent[1].

Legal and Procedural Context

Understanding the legal and procedural context is crucial. For example:

Terminal Disclaimers

If a terminal disclaimer is filed to overcome ODP rejections, it affects the patent term. The patent term extension due to PTA does not extend past the date of the terminal disclaimer[1].

Use of AI Tools

In modern patent practice, AI tools may be used to assist in drafting and searching. However, it is essential to ensure that all statements in the patent application are true and based on information believed to be true. Any material contributions by AI must be disclosed to the USPTO[5].

Challenges and Considerations

Equitable Concerns

In cases like In re Cellect LLC, the Board considered equitable concerns underlying ODP findings. This includes ensuring that the patent system does not allow an inventor to secure a second, later-expiring patent for the same invention[1].

International Considerations

For patents filed internationally, understanding the complexities of multi-jurisdiction filing and inconsistencies in indexing across databases is vital. This includes considering the US-JP Collaborative Search Pilot Program, which can provide insights into patentability across different jurisdictions[4].

Key Takeaways

  • Patent Claims: The claims define the scope of the invention and must be carefully constructed and interpreted.
  • Prior Art and ODP: Understanding prior art and ODP is crucial for determining the validity and scope of a patent.
  • Legal and Procedural Context: Terminal disclaimers, PTA, and the use of AI tools all impact the patent landscape.
  • International Considerations: Multi-jurisdiction filing and collaborative search programs can provide valuable insights.

FAQs

Q: What are the basic criteria for patentability in the United States?

A: The basic criteria are novelty, usefulness, and nonobviousness.

Q: How does ODP affect patent term adjustments?

A: ODP analysis should be based on the adjusted expiration date of the patent, and PTA does not extend the term past the date of a terminal disclaimer[1].

Q: Can AI tools be used in drafting patent applications?

A: Yes, but all statements must be reviewed and verified for accuracy, and material contributions by AI must be disclosed to the USPTO[5].

Q: What is the significance of patent families in patent analysis?

A: Understanding patent families helps in making informed decisions about licensing, challenging validity, and allocating R&D resources[3].

Q: How do terminal disclaimers impact patent term extensions?

A: Terminal disclaimers filed to overcome ODP rejections affect the patent term, and PTA does not extend the term past the date of the terminal disclaimer[1].

Sources

  1. In re Cellect - United States Court of Appeals for the Federal Circuit
  2. THE U.S. PATENT APPLICATION PROCESS - SBIR
  3. Advanced patent searching techniques - CAS.org
  4. US-JP Collaborative Search Pilot Program - Japan Patent Office
  5. U.S. Patent Office Issues Additional Guidance on Use of AI Tools - BIPC

More… ↓

⤷  Try for Free

Details for Patent 5,428,522

ApplicantTradenameBiologic IngredientDosage FormBLAApproval DatePatent No.Expiredate
Sanofi Pasteur Sa IPOL poliovirus vaccine inactivated Injection 103930 February 04, 2000 ⤷  Try for Free 2040-01-29
>Applicant>Tradename>Biologic Ingredient>Dosage Form>BLA>Approval Date>Patent No.>Expiredate
Showing 1 to 1 of 1 entries

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.